healthcare

Image for England confirms 34 COVID cases linked to highly mutated variant – UKSHATop Stories

England Confirms 34 Covid Cases Linked to Highly Mutated Variant – Uksha

Image for Tonix’s long COVID drug fails to meet mid-stage trial goalTop Stories

Tonix’s Long Covid Drug Fails to Meet Mid-Stage Trial Goal

Image for Novo Nordisk launches weight-loss drug Wegovy in BritainTop Stories

Novo Nordisk Launches Weight-Loss Drug Wegovy in Britain

Image for England to rollout world-first seven-minute cancer treatment jabTop Stories

England to Rollout World-First Seven-Minute Cancer Treatment Jab

Image for US CDC tracks new lineage of virus that causes COVID

US Cdc Tracks New Lineage of Virus That Causes Covid

Date: August 18, 2023

US CDC tracks new lineage of virus that causes COVID By Deena Beasley (Reuters) – U.S. Centers for Disease Control and Prevention said on Thursday that it was tracking a new, highly mutated lineage of the virus that causes COVID-19. The lineage is named BA.2.86, and has been detected in the United States, Denmark and...

Image for Fresenius Medical forecasts smaller income decline as cost inflation eases

Fresenius Medical Forecasts Smaller Income Decline as Cost Inflation Eases

Date: August 2, 2023

Fresenius Medical forecasts smaller income decline as cost inflation eases By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters) – Dialysis group Fresenius Medical Care on Wednesday said a possible earnings fall this year would likely not be as pronounced as previously feared, helped by cost cuts, and as labour shortages and cost inflation slowly ease....

Image for UK health regulator approves GSK’s vaccine for common respiratory virus RSV

UK Health Regulator Approves GSK’s Vaccine for Common Respiratory Virus Rsv

Date: July 10, 2023

UK health regulator approves GSK’s vaccine for common respiratory virus RSV (Reuters) -Britain’s health regulator approved GSK’s vaccine for the respiratory syncytial virus (RSV), which causes thousands of hospitalisations and deaths annually, the drugmaker said on Monday. The Medicines and Healthcare products Regulatory Agency (MHRA) authorised GSK’s shot, called Arexvy, for active immunisation to prevent...

Image for Analysis-Europe faces long wait for weight-loss drugs as governments eye costs

Analysis-Europe Faces Long Wait for Weight-Loss Drugs as Governments Eye Costs

Date: July 10, 2023

Analysis-Europe faces long wait for weight-loss drugs as governments eye costs By Ludwig Burger and Andreas Rinke FRANKFURT (Reuters) – Novo Nordisk will start selling its hugely popular obesity drug Wegovy in Germany this month, its third European market, but only people who pay from their own pocket or have certain private health insurance plans...

Image for UK high-sugar promotion ban delay angers health campaigners

UK High-Sugar Promotion Ban Delay Angers Health Campaigners

Date: June 19, 2023

UK high-sugar promotion ban delay angers health campaigners LONDON (Reuters) -Britain’s decision to further delay rules banning multi-buy deals on food and drinks high in fat, salt, or sugar (HFSS) has dismayed health campaigners who say it will not help families trying to save money. The UK government said on Saturday that rules banning multi-buy...

Image for The Risks and Rewards of Investing in Biotech and Pharmaceutical Stocks

The Risks and Rewards of Investing in Biotech and Pharmaceutical Stocks

Date: June 13, 2023

Investing in biotech and pharmaceutical stocks offers a unique opportunity to be part of the dynamic healthcare industry. This article explores the importance of these stocks and provides an overview of the associated risks and rewards, helping investors make informed decisions. Importance of Biotech and Pharmaceutical Stocks Biotech and pharmaceutical stocks play a vital role...